Esteban Lopez Sells 150 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) Director Esteban Lopez sold 150 shares of Addus HomeCare stock in a transaction on Monday, December 15th. The shares were sold at an average price of $115.18, for a total value of $17,277.00. Following the sale, the director directly owned 3,700 shares in the company, valued at $426,166. The trade was a 3.90% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Esteban Lopez also recently made the following trade(s):

• On Friday, December 5th, Esteban Lopez sold 166 shares of Addus HomeCare stock. The stock was sold at an average price of $112.78, for a total value of $18,721.48.

Addus HomeCare Price Performance

Shares of ADUS opened at $112.98 on Thursday. Addus HomeCare Corporation has a one year low of $88.96 and a one year high of $136.72. The stock’s fifty day moving average is $115.84 and its 200-day moving average is $113.83. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.66 and a current ratio of 1.66. The firm has a market capitalization of $2.09 billion, a price-to-earnings ratio of 24.19, a price-to-earnings-growth ratio of 1.52 and a beta of 0.94.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, November 3rd. The company reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.53 by $0.03. The firm had revenue of $362.30 million during the quarter, compared to analyst estimates of $354.48 million. Addus HomeCare had a net margin of 6.36% and a return on equity of 9.53%. Addus HomeCare’s revenue was up 25.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.30 EPS. Equities analysts anticipate that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on ADUS. Royal Bank Of Canada increased their price objective on shares of Addus HomeCare from $134.00 to $139.00 and gave the company an “outperform” rating in a report on Friday, November 7th. Barclays upped their target price on Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 4th. Stephens reissued an “overweight” rating and issued a $140.00 price objective on shares of Addus HomeCare in a research note on Wednesday, September 3rd. Cowen restated a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Finally, UBS Group initiated coverage on Addus HomeCare in a report on Tuesday, September 2nd. They set a “buy” rating and a $145.00 target price on the stock. Eight equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $137.11.

Hedge Funds Weigh In On Addus HomeCare

A number of hedge funds have recently modified their holdings of ADUS. Hohimer Wealth Management LLC increased its position in Addus HomeCare by 3.4% during the third quarter. Hohimer Wealth Management LLC now owns 2,709 shares of the company’s stock worth $320,000 after acquiring an additional 88 shares during the period. Ameritas Investment Partners Inc. boosted its holdings in Addus HomeCare by 5.0% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 1,854 shares of the company’s stock valued at $214,000 after purchasing an additional 89 shares during the period. Amalgamated Bank grew its position in Addus HomeCare by 1.8% in the 3rd quarter. Amalgamated Bank now owns 5,240 shares of the company’s stock worth $618,000 after purchasing an additional 93 shares during the last quarter. First Hawaiian Bank increased its holdings in shares of Addus HomeCare by 2.0% during the 1st quarter. First Hawaiian Bank now owns 4,898 shares of the company’s stock worth $484,000 after purchasing an additional 95 shares during the period. Finally, Maryland State Retirement & Pension System increased its holdings in shares of Addus HomeCare by 1.9% during the 2nd quarter. Maryland State Retirement & Pension System now owns 5,335 shares of the company’s stock worth $615,000 after purchasing an additional 101 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.